C-reactive protein levels increased in association with higher concentrations of air pollutants; risk for flare increased
TUESDAY, Nov. 2, 2021 (HealthDay News) — Air pollution is associated with increased rheumatoid arthritis (RA) disease severity, according to a study published in the October issue of Rheumatology.
Giovanni Adami, M.D., Ph.D., from the University of Verona in Italy, and colleagues collected longitudinal data of patients affected by RA and the daily concentrations of air pollutants in the Verona area to examine the correlation between RA flares and air pollution in a case-crossover study. Exposure to pollutants was compared in the 30- and 60-day periods preceding an arthritic flare relative to the 30- and 60-day exposure preceding a low-disease activity visit.
Data were included for 888 RA patients with 3,396 follow-up visits. The researchers identified an exposure-response relationship between air pollutant concentration and the risk for having abnormal C-reactive protein (CRP) levels. The risk for having CRP levels ≥5 mg/L were increased for patients exposed to higher concentrations of air pollutants. In the 60-day period preceding a flare, concentrations of carbon monoxide, nitric oxide, nitrogen dioxide, oxides of nitrogen, particulate matter with a diameter of 2.5 µm or less, and ozone were higher.
“The excessive risk was seen even at very low levels of exposure, even below the proposed threshold for the protection of human health,” the authors write. “Our study has important and direct consequences. In order to reduce the burden of RA, public and environmental health policy makers should aim to diminish gaseous and particulate matter emissions to a larger extent than currently recommended.”
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease
Exposure to Air Pollutants Linked to Increased RA Disease Activity
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA